Clindamycin Phosphate
Back to searchMolecule Structure
Scientific Name
Clindamycin Phosphate
Brand Name(s)
Cleocin, Cleocin phosphate, Cleocin t, Clinda-derm, Clindagel, Clindamycin phosphate, Clindesse, Clindets, Dalacin, Dalacin c phos, Dalacin t, Evoclin, Xaciato, Zindaclin
Company Owner(s)
Igi Laboratories Inc, Watson Laboratories Inc, Fougera Pharmaceuticals Inc, Actavis Mid Atlantic Llc, Taro Pharmaceuticals Usa Inc, Glenmark Pharmaceuticals Sa, Abbott Laboratories, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Boca Pharmacal Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL37148 | ||||
| PubChem: Thomson Pharma | 14860117 | 14933496 | |||
| PubChem | 443385 | ||||
| Nikkaji | J286.383I | ||||
| BindingDB | 241975 | ||||
| EPA CompTox Dashboard | DTXSID1048677 | ||||
| DrugCentral | 3909 | ||||
| ChemicalBook | CB8175076 | ||||
| rxnorm | CLINDAMYCIN PHOSPHATE | CLINDESSE | CLINDAGEL | EVOCLIN | CLEOCIN |
| ZINC | ZINC000004102185 |
